Linarin may represent a promising adjunct therapeutic agent for overcoming resistance to conventional chemotherapeutic drugs, mediated through PTEN upregulation, which appears to play a role in suppressing P-gp-associated resistance mechanisms.
Vahid Mahmoudzadeh, Mehran Molavand, Azita Asadi et al.· Advanced Pharmaceutical Bull...· 0 citations
Cancer is among the leading causes of global mortality. In addition to uncontrolled proliferation, cancer cells activate survival pathways that favor the expansion of malignant cell populations. A critical component of these survival mechanisms is drug resistance, which often prevents the achievement of optimal therape...
Mehran Molavand, Amir Valizadeh, M. Majidinia et al.· Advanced Pharmaceutical Bull...· 0 citations
Linarin demonstrates the capacity to potentiate 5-FU cytotoxicity by reactivating the p53/p21 pathway in CRC models harboring functional p53 by reactivating the p53/p21 pathway in linarin's sensitizing action in p53-competent cells.
Amir Valizadeh, M. Rahmati-Yamchi, A. Alihemmati et al.· Advanced Pharmaceutical Bull...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.